# Filing Detail

Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001615774-16-008635
Filing Date
2016-11-30
Accepted
2016-11-30 16:53:12
Documents
18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | primary_doc.html | 1-A/A |
1 |  | primary_doc.xml | 1-A/A | 15737
2 | PART II AND III | s104807_partiiandiii.htm | PART II AND III | 723975
3 | EX1A-11 CONSENT | s104807_ex11-1.htm | EX1A-11 CONSENT | 3796
4 | EX1A-12 OPN CNSL | s104807_ex12-1.htm | EX1A-12 OPN CNSL | 8138
5 | EX1A-13 TST WTRS | s104807_ex13-1.htm | EX1A-13 TST WTRS | 4869
6 | GRAPHIC | tlogo.jpg | GRAPHIC | 24164
7 | GRAPHIC | pg1img1_ex12-1.jpg | GRAPHIC | 19727
8 | GRAPHIC | pg1img2_ex12-1.jpg | GRAPHIC | 8262
9 | GRAPHIC | pg1_ex13-1.jpg | GRAPHIC | 223397
10 | GRAPHIC | pg2_ex13-1.jpg | GRAPHIC | 310164
11 | GRAPHIC | pg3_ex13-1.jpg | GRAPHIC | 123860
12 | GRAPHIC | pg4_ex13-1.jpg | GRAPHIC | 1464363
13 | GRAPHIC | pg5_ex13-1.jpg | GRAPHIC | 164631
14 | GRAPHIC | pg6_ex13-1.jpg | GRAPHIC | 240153
15 | GRAPHIC | pg7_ex13-1.jpg | GRAPHIC | 340130
16 | GRAPHIC | pg8_ex13-1.jpg | GRAPHIC | 341492
17 | GRAPHIC | pg9_ex13-1.jpg | GRAPHIC | 205380
18 | GRAPHIC | pg10_ex13-1.jpg | GRAPHIC | 140941
| Complete submission text file | 0001615774-16-008635.txt |  | 5726615

Mailing Address 50 W. BROADWAY 3RD FLOOR SALT LAKE CITY X1 84101
Business Address 50 W. BROADWAY 3RD FLOOR SALT LAKE CITY X1 84101 9493465822
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 1-A/A | Act: 33 | File No.: 024-10637 | Film No.: 162025766
SIC: 2834 Pharmaceutical Preparations